Efficacy of Virtual Reality Exercises in STroke Rehabilitation: A Multicentre Study (EVREST Multicentre)
1 other identifier
interventional
141
5 countries
13
Brief Summary
A multicentre, randomized, two parallel group study comparing virtual reality using Wii gaming technology versus Recreational activities in patients receiving conventional rehabilitation after an ischemic stroke. Primary Hypothesis: Virtual reality using the Wii gaming system is more efficacious in improving motor function than recreational therapy among patients receiving conventional rehabilitation following a recent ischemic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2011
Longer than P75 for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 25, 2011
CompletedFirst Posted
Study publicly available on registry
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedNovember 13, 2015
November 1, 2015
4.3 years
July 25, 2011
November 11, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in motor performance between groups measured using the Wolf Motor function Test.
Efficacy in motor function improvement at the end of the intervention will be measured by the abbreviated Wolf Motor Function Test. The Wolf MFT is a time-based method to evaluate upper extremity performance while providing insight into total limb movements. It consists of 15 timed measures and 2 force-based measures which progress in complexity. Difference in Wolf MFT is one of the most commonly used outcome measures in stroke rehabilitation trials.
1 (±3) days after the end of the intervention
Secondary Outcomes (2)
Improvement in motor function, performing activities of daily living, and quality of life, as well as sustainability of motor improvement
End of intervention and 4 weeks post-intervention
Proportion of patients experiencing intervention-related adverse events or any serious adverse events during the study period
Subjects will be followed for the duration of their participation in the study, an expected time frame of 6 weeks
Study Arms (2)
Recreational Activity Arm
ACTIVE COMPARATORrecreational activity includes playing cards, ominoes, jenga or a ball game.
Wii Gaming System Arm
EXPERIMENTALUse of Wii gaming technology (e.g. commercially available games)
Interventions
Recreational activities (playing cards, arts and crafts, dominoes, jenga or a ball game) and conventional rehabilitation.
Virtual reality Wii games (tennis and bowling from Wii® Sports, and bean bag, bocce ball, ping cup, darts or shuffleboard from Wii® Game Party 3) and conventional rehabilitation.
Eligibility Criteria
You may qualify if:
- Patient has provided written informed consent prior to entry into the study
- Males or females, aged 18 to 85 years
- In-patient at the time of randomization
- Evidence of ischemic stroke confirmed by CT or MRI head scan
- Patients with onset of symptoms less than 3 months at time of randomization
- Measurable deficit of the upper extremity (arm) equal to or greater than 3 according to the Chedoke McMaster scale (e.g.: participants should be able to touch their chin and contralateral knee to be eligible)
- Functional independence prior to present stroke (baseline mRS = 0-1)
- Patient is alert, medically stable according to the treating physician and able to follow simple verbal commands
You may not qualify if:
- Acute stroke onset more than 3 months ago
- Patient is unable to follow verbal commands or has global aphasia
- Severe illness and life expectancy less than 3 months (cancer, endocarditis, metastasis with an occult primary malignancy, coagulopathy)
- Uncontrolled hypertension according to the treating physician
- Unstable angina or recent myocardial infarction (within the last 3 months), current NY Heart Association Class III (marked limitation of physical activity; although patients are comfortable at rest, less-than-ordinary activity leads to fatigue, dyspnea, palpitations, or angina) or IV (symptomatic at rest; symptoms of CHF are present at rest; discomfort increases with any physical activity) or symptomatic ventricular tachyarrhythmias, as per medical history (a baseline ECG will not be required.)
- Any history of seizure, except for febrile seizures of childhood
- Pain or joint problems limiting movement of the arm (e.g. shoulder pain)
- Participation in another clinical trial involving rehabilitation (recreational therapy, occupational therapy, physiotherapy) or involving an investigational drug
- Patient is unwilling or unable to comply with the protocol or cannot / will not cooperate fully with the investigator or study personnel
- Any medical condition that might confound the interpretation of results or put the patient at risk (amputation of one extremity).
- Enrollment Criteria
- Upon meeting all eligibility criteria and providing written informed consent, the patient will be enrolled into the study contingent on successfully completing a one hour training session with Virtual Reality Wii.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unity Health Torontolead
- Heart and Stroke Foundation of Ontariocollaborator
- Ontario Stroke Networkcollaborator
- Ontario Ministry of Health and Long Term Carecollaborator
Study Sites (13)
FLENI
Buenos Aires, Buenos Aires, Argentina
Lucy Montoro Network
São Paulo, Brazil
University of Calgary
Calgary, Alberta, T2N 0P8, Canada
Riverview Health Centre
Winnipeg, Manitoba, R3L 2P4, Canada
LA Miller Centre
St. John's, Newfoundland and Labrador, Canada
Hamilton Health Sciences
Hamilton, Ontario, L8L 2X2, Canada
Parkwood Hospital, St. Joseph's Health Care London
London, Ontario, N6C 5J1, Canada
Trillium Health Partners
Mississauga, Ontario, L5B 1B8, Canada
Providence Healthcare
Scarborough Village, Ontario, M1L 1W1, Canada
Toronto Rehabilitation Institute
Toronto, Ontario, M5G 2A2, Canada
CSSS Cavendish Richardson Hospital
Montreal, Quebec, Canada
Clinica San Felipe
Lima, Peru
Siriraj Hospital
Bangkok, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gustavo Saposnik, MD
Unity Health Toronto
- PRINCIPAL INVESTIGATOR
Mark Bayley, MD
Toronto Rehabilitation Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2011
First Posted
August 1, 2011
Study Start
July 1, 2011
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
November 13, 2015
Record last verified: 2015-11